Trend Analysis Report: Alphabet Inc (NASDAQ:GOOG), Select Medical Holdings Corporation (NYSE:SEM)

On Tuesday, Shares of Alphabet Inc (NASDAQ:GOOG), added 1.02% and closed at $790.51 in the last trading session. The last trading range of the stock ranges between $780.19 and $795.63. The company’s Market capitalization is $566.47 Billion with the total Outstanding Shares of 345.09 million. Alphabet Inc., through its auxiliaries, provides online advertising services in the United States, the United Kingdom, and rest of the world. The company offers performance and brand advertising services. It operates through Google and Other Bets segments. The Google segment includes principal Internet products, such as Search, Ads, Commerce, Maps, YouTube, Apps, Cloud, Android, Chrome, and Google Play, in addition to technical infrastructure and newer efforts, such as Virtual Reality.

Select Medical Holdings Corporation (NYSE:SEM), dropped -0.43% and closed at $11.45 in the last trading session. The last trading range of the stock ranges between $10.85 and $11.60. The company’s Market capitalization is $1.56 Billion with the total Outstanding Shares of 132.33 million. Select Medical Holdings Corporation (“Select Medical”) (SEM) today announced results for its third quarter ended September 30, 2016.

For the third quarter ended September 30, 2016, net operating revenues increased 3.2% to $1,053.8 million, compared to $1,021.1 million for the same quarter, prior year.  Income from operations increased 16.5% to $56.2 million for the third quarter ended September 30, 2016, compared to $48.2 million for the same quarter, prior year.  Net income was $4.0 million for the third quarter ended September 30, 2016, which includes a pre-tax non-operating loss of $1.0 million and a pre-tax loss on early retirement of debt of $10.9 million. Net income was $32.8 million for the third quarter ended September 30, 2015, which includes a pre-tax non-operating gain of $29.6 million. Earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, Concentra acquisition costs, Physiotherapy acquisition costs, non-operating gain (loss), and equity in earnings (losses) of unconsolidated subsidiaries (“Adjusted EBITDA”) for the third quarter ended September 30, 2016 increased 16.1% to $98.1 million, compared to $84.5 million for the same quarter, prior year.  During the third quarter ended September 30, 2016, we incurred Adjusted EBITDA losses for start-up hospitals of approximately $9.0 million. A reconciliation of net income to Adjusted EBITDA is presented in table VIII of this release. Income per common share for the third quarter ended September 30, 2016 was $0.05 on a fully diluted basis, compared to income per common share of $0.22 for the same period, prior year. Excluding the non-operating loss, loss of early retirement of debt, and related tax effects, adjusted income per common share was $0.06 per diluted share for the third quarter ended September 30, 2016. Excluding the non-operating gain and related tax effect, adjusted income per common share was $0.08 per diluted share for the third quarter ended September 30, 2015. A reconciliation of income per common share to adjusted income per common share for both the third quarters ended September 30, 2016 and 2015 is presented in table IX of this release.

 

Leave a Reply

Your email address will not be published. Required fields are marked *